Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH
USE OUR INTELLIGENCE

Less Than a Third of FDA Regulatory Actions Backed by Research or Public Assessments
POLICY & LAW
October 6, 2022

Less Than a Third of FDA Regulatory Actions Backed by Research or Public Assessments

Less than a third of regulatory actions taken by the US Food and Drug Administration…

USE OUR INTELLIGENCE October 6, 2022
Mother’s Ultra-Processed Food Intake Linked to Obesity Risk in Children
PUBLIC HEALTH
October 6, 2022

Mother’s Ultra-Processed Food Intake Linked to Obesity Risk in Children

A mother’s consumption of ultra-processed foods appears to be linked to an increased risk of…

USE OUR INTELLIGENCE October 6, 2022
Liver Cancer Cases and Deaths Projected to Rise by More Than 55% by 2040
DISEASES
October 6, 2022

Liver Cancer Cases and Deaths Projected to Rise by More Than 55% by 2040

A new analysis reveals that primary liver cancer was among the top three causes of…

USE OUR INTELLIGENCE October 6, 2022
ProDERM Study Results of Octagam 10% Treatment in Patients with Dermatomyositis Published in the New England Journal of Medicine
RESEARCH
October 6, 2022

ProDERM Study Results of Octagam 10% Treatment in Patients with Dermatomyositis

Octapharma announced today the results from the ProDERM study on the efficacy and safety of Octagam® 10%  [Immune…

USE OUR INTELLIGENCE October 6, 2022
When Endings Approach, People Choose the Familiar Over the Novel
RESEARCH
October 6, 2022

When Endings Approach, People Choose the Familiar Over the Novel

When people believe that a door is closing — that they have a limited amount…

USE OUR INTELLIGENCE October 6, 2022
114 Million Americans Think the U.S. Healthcare System Is Failing Them
PUBLIC HEALTH
October 6, 2022

114 Million Americans Think the U.S. Healthcare System Is Failing Them

Nearly half the country (44%), or about 114 million Americans, give poor (30%) or failing…

USE OUR INTELLIGENCE October 6, 2022
Schizophrenia May Increase Dementia Risk by 2.5 Times
NEUROLOGY & MENTAL HEALTH
October 6, 2022

Schizophrenia May Increase Dementia Risk by 2.5 Times

People with psychotic disorders such as schizophrenia are 2.5 times more likely than those without…

USE OUR INTELLIGENCE October 6, 2022
Discovery of a New Function of the Cerebellum
NEUROLOGY & MENTAL HEALTH
October 6, 2022

Discovery of a New Function of the Cerebellum

The cerebellum is known primarily for regulation of movement. Researchers at the University of Basel…

USE OUR INTELLIGENCE October 6, 2022
Dodging Death: Surprise Discovery Redirects Efforts for Treatment of Liver Disease
DISEASES
October 6, 2022

Dodging Death: Surprise Discovery Redirects Efforts for Treatment of Liver Disease

WEHI researchers have revealed that common liver diseases are not driven by inflammatory cell death…

USE OUR INTELLIGENCE October 6, 2022
Wear and Tear from Lifelong Stress Can Increase Cancer Mortality
DISEASES
October 6, 2022

Wear and Tear from Lifelong Stress Can Increase Cancer Mortality

The wear and tear on the body from chronic and lifelong stress can also lead…

USE OUR INTELLIGENCE October 6, 2022
Older Posts Newer Posts
Latest Posts
  • Check for Copycat Bias in Medical AI
    TECHNOLOGY
    Check for Copycat Bias in Medical AI
    USE OUR INTELLIGENCE September 2, 2026
  • Brain Cancer: Immunotherapy First, Surgery Afterwards
    NEUROLOGY & MENTAL HEALTH, PHARMA & CLINICAL TRIALS
    Brain Cancer: Immunotherapy First, Surgery Afterwards
    USE OUR INTELLIGENCE September 2, 2026
  • Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    TECHNOLOGY
    Your Smartwatch Is Lying to You About How Many Calories You Burned, FIU Study Finds
    USE OUR INTELLIGENCE September 2, 2026
  • FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    PHARMA & CLINICAL TRIALS
    FDA Approves Breakthrough Pancreatic Cancer Drug – an Oncologist Explains How Daraxonrasib Nearly Doubles Survival
    USE OUR INTELLIGENCE September 2, 2026
  • Not All ‘Magic’ Mushrooms Are the Same
    PUBLIC HEALTH
    Not All ‘Magic’ Mushrooms Are the Same
    USE OUR INTELLIGENCE September 2, 2026
Global Health News Wire
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

Global Health News Wire
  • HOME
  • GHNW Notes
  • PERMISSIONS AND POLICIES
  • VIRUSES & VACCINES
  • PUBLIC HEALTH
  • NEUROLOGY & MENTAL HEALTH
  • DISEASES
  • PHARMA & CLINICAL TRIALS
  • TECHNOLOGY
  • POLICY & LAW
  • ENVIRONMENT
  • RESEARCH

©2026. Global Health News Wire. Use Our Intel. All Rights Reserved. Washington, D.C.

I would like to receive critical industry news to my inbox.

Our site uses cookies. Learn more about our use of cookies: Cookie Policy

ACCEPT